These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
856 related articles for article (PubMed ID: 3108402)
1. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma. Guerry D; Alexander MA; Elder DE; Herlyn MF J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402 [TBL] [Abstract][Full Text] [Related]
2. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells. Herlyn M; Guerry D; Koprowski H J Immunol; 1985 Jun; 134(6):4226-30. PubMed ID: 2985706 [TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma. Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738 [TBL] [Abstract][Full Text] [Related]
4. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease. Alexander MA; Bennicelli J; Guerry D J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732 [TBL] [Abstract][Full Text] [Related]
5. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711 [TBL] [Abstract][Full Text] [Related]
6. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts. Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281 [TBL] [Abstract][Full Text] [Related]
7. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635 [TBL] [Abstract][Full Text] [Related]
8. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells. Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076 [TBL] [Abstract][Full Text] [Related]
9. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589 [TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens. Carrel S; Schmidt-Kessen A; Giuffrè L Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869 [TBL] [Abstract][Full Text] [Related]
11. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479 [TBL] [Abstract][Full Text] [Related]
12. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition. Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004 [TBL] [Abstract][Full Text] [Related]
13. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. Geppert TD; Lipsky PE J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon. Masuyama J; Minato N; Kano S J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells. Howard DR; Eaves AC; Takei F Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652 [TBL] [Abstract][Full Text] [Related]
16. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. Shaw AR; Chan JK; Reid S; Seehafer J J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246 [TBL] [Abstract][Full Text] [Related]
17. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells. Kanner SB; Odum N; Grosmaire L; Masewicz S; Svejgaard A; Ledbetter JA J Immunol; 1992 Dec; 149(11):3482-8. PubMed ID: 1385526 [TBL] [Abstract][Full Text] [Related]
18. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP. Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208 [TBL] [Abstract][Full Text] [Related]
19. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens. Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes. Ogasawara M; Rosenberg SA Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]